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Objective: To determine if a hybrid cardiac
rehabilitation (CR) programme using the Family-
Centered Empowerment Model (FCEM) as compared
with standard CR will improve patient quality of life,
perceived stress and state anxiety of patients with
myocardial infarction (MI).
Methods: We conducted a randomised controlled trial
in which patients received either standard home CR or
CR using the FCEM strategy. Patient empowerment was
measured with FCEM questionnaires preintervention
and postintervention for a total of 9 assessments.
Quality of life, perceived stress, and state and trait
anxiety were assessed using the 36-Item Short Form
Health Survey (SF-36), the 14-item Perceived Stress,
and the 20-item State and 20-item Trait Anxiety
questionnaires, respectively.
Results: 70 patients were randomised. Baseline
characteristics were similar. Ejection fraction was
significantly higher in the intervention group at
measurements 2 (p=0.01) and 3 (p=0.001). Exercise
tolerance measured as walking distance was
significantly improved in the intervention group
throughout the study. The quality of life results in the
FCEM group showed significant improvement both
within the group over time (p<0.0001) and when
compared with control (p<0.0001). Similarly, the
perceived stress and state anxiety results showed
significant improvement both within the FCEM group
over time (p<0.0001) and when compared with control
(p<0.0001). No significant difference was found either
within or between groups for trait anxiety.
Conclusions: The family-centred empowerment
model may be an effective hybrid cardiac rehabilitation
method for improving the physical and mental health
of patients post-MI; however, further study is needed
to validate these findings. Clinical Trials.gov identifier
NCT02402582.
Trial registration number: NCT02402582.
INTRODUCTION
Cardiovascular disease (CVD) is a leading
cause of death worldwide, accounting for
30% of global deaths.1 Over the next few
decades, CVD will continue as the leading
KEY QUESTIONS
What is already known about this subject?
▸ Cardiac rehabilitation (CR) is an outpatient
model of chronic disease management for sec-
ondary cardiovascular disease (CVD) prevention.
It is a class I indication for patients with coron-
ary heart disease. The use of CR post-
myocardial infarction (post-MI) has been shown
to improve function and exercise capacity,
decrease morbidity and mortality, and also
improves quality of life, perceived stress and
anxiety. Hence, CR serves as a key tool in
addressing the global burden of CVD. Despite
recommendations, CR remains underutilised
with low participation and adherence rates both
in high income countries and low and middle
income countries (LMICs). Home-based and
hybrid CR programmes developed as a means
to increase patient access, compliance and
enrolment.
▸ The Family-Centered Empowerment Model
(FCEM) was designed to improve the care and
outcomes of patients with chronic diseases and
has previously been evaluated and validated in a
number of chronic disease states. Previously, it
has been shown that the FCEM model may be
feasible to use in the cardiac setting. Moreover,
it has been reported to be effective among
patients undergoing coronary artery bypass
surgery. Its use in the non-surgical post-MI
setting has not been defined.
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cause of mortality worldwide.2 3 Furthermore, the
burden of CVD is growing disproportionately in low and
middle income countries (LMICs), where 80% of CVD
deaths occur.4 Myocardial infarction (MI) is a leading
cause of CVD-associated morbidity and mortality.5–7
Recurrent MI within 5 years is common, affecting
15–22% of patients’ aged 45–64 years and 22% of
patients aged >65 years.6 In addition to the physical toll,
an MI may cause or exacerbate significant mental health
comorbid conditions.
The health-related quality of life (HRQoL) is increas-
ingly being used as an outcome measure of coronary
heart disease.8–10 As the population ages and survival of
ischaemic coronary events continues to improve, assess-
ment of HRQoL is necessary as an important and useful
outcome measure complementing the traditional ‘hard
outcomes’ such as mortality and recurrent MI for evalu-
ating impact of disease and benefits of medical interven-
tions.8 Post-MI increases in patient stress may translate
into worse HRQoL.6 11–13 Evidence suggests that a
decline in health status is associated with worse progno-
sis, disease progression and healthcare outcomes in
patients with cardiac disease.12 14–16
Cardiac rehabilitation (CR) is an outpatient model of
chronic disease management for secondary CVD pre-
vention. It is a class I indication for patients with coron-
ary heart disease.17 In a meta-analysis, the use of CR
post-MI has been shown to improve function and exer-
cise capacity, decrease morbidity and mortality, and also
improves quality of life, perceived stress and anxiety.1 18
Hence, CR serves as a key tool in addressing the global
burden of CVD.1 Despite recommendations, CR
remains underutilised with low participation and adher-
ence rates in both high income and LMICs.1 The
reasons for CR underuse include geographic access,
cost, organisational and patient factors, and patient
education and understanding of the nature of CR and
the associated benefits.19–21 Participation in home-based
or hybrid CR programmes is associated with cost-
effective and equivalent benefits to supervised pro-
grammes.22–24 With advances in technology, hybrid
home-based programmes have been developed that
incorporate email, secure websites and videoconferen-
cing between patients and providers. Recently, the
utility of smartphone applications has also been
investigated.21
The Family-Centered Empowerment Model (FCEM)
was designed and first reported by Dr Fatemah Ahlani at
Tarbiat Modarres University.25 It’s aim was to improve
the care and outcomes of patients with chronic diseases
and has previously been evaluated and validated in a
number of chronic disease states.7 26–32 The primary aim
of the model is to empower the patient/family unit to
promote health quality. The model has four stages: (1)
determining perceived threat (group discussion
method); (2) self-efficacy (problem-solving method);
(3) improving self-esteem (educational participation
method) and (4) process and outcome evaluations. We
investigated the impact that an FCEM-focused hybrid CR
programme employing in-hospital and outpatient com-
ponents, direct education, video teleconferencing and
smartphone technology had on patient anxiety and per-
ceived stress, and overall quality of life has measured by
HRQoL among patients hospitalised with acute MI
(AMI) in a coronary care unit (CCU).
METHODS
Study design
We conducted a randomised controlled blinded study in
patients admitted for MI to the CCU of an academic
teaching hospital from June 2012 to January 2015. The
study was approved by the institutional investigative
review board at Tarbiat Modares University and
Baqiyatallah University of Medical Sciences and regis-
tered with Clinical Trials.gov (identifier NCT02402582).
Inclusion criteria were: (1) age 45–85 years, (2) able and
willing to provide informed consent, (3) willingness of
designated family member or friend to participate, (4) is
able to read, write, and fill out the questionnaire, (5)
diagnosed with an AMI and (6) first hospitalisation for
AMI. MI was diagnosed in accordance with established
criteria including (1) clinical symptoms, (2) serum tests
(eg, troponin and creatine kinase (CK)-MB) and (3)
characteristic changes on the ECG. Cardiac catheterisa-
tion data were not routinely available. Patients had not
previously gone through CR programmes. The differ-
ence between the two groups was not disclosed at any
point. Patients consented knowing that they would
receive cardiac rehabilitation, but without knowing the
details. Patients and their designated family/friend were
enrolled as a ‘unit’.
Power calculations determined that 32 patient/family
units were needed in each group to achieve a 95% confi-
dence level and a 90% power. Participant enrolment was
via convenience sampling. Block randomisation was
KEY QUESTIONS
What does this study add?
▸ CR remains underutilised and with high rates of patient attri-
tion. This study utilises an approach to support structure
engagement that has not previously been used in the post-MI
population. Marked improvements in patient perceived physical
and mental wellness as well as quality of life were observed.
Improvements in ejection fraction and exercise tolerance were
also observed. This strategy may effectively augment home CR
to improve its effectiveness.
How might this impact on clinical practice?
▸ This study suggests that use of the FCEM to augment home
CR may improve patients’ physical health, mental health and
quality of life versus attenuating the decline that may occur fol-
lowing discharge for acute MI. This may have the greatest clin-
ical implications in resource-limited settings where CR access
is low and attrition rates are high.
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accomplished by a computer-generated random number
list prepared by an expert statistician who had no clinical
involvement in the trial. Allocation consignment was
performed by the hospital clinical supervisor, who was
not involved in the recruitment process. Patients and
their family members, clinical nurses and data analyser
were blind to the allocation. Analyses were performed as
intention-to-treat.
Intervention
The intervention package had three phases including
the preintervention, intervention and postintervention
phases (figure 1).
Preintervention
During the preintervention phase, patients filled out
questionnaires concerning quality of life, perceived
stress and anxiety. A rehabilitation plan was formulated
incorporating considerations for the patient’s identified
strengths’ and weaknesses. See the CR section.
Intervention
Once discharged, patients called their study nurse every
2 days to report any problems or complications. Patients
were evaluated by their primary cardiologist on a weekly
basis and at 30 days. These examinations included
history and physical examination, an ECG, and echocar-
diogram and laboratory tests as indicated. At other
times, if patients experienced a problem or complica-
tion, they notified investigators and presented to either
their primary cardiologist or their primary care provider
for evaluation. Patients in the intervention group
received care employing the FCEM in four stages. Stage 1
of the intervention was awareness and cognition. The
patient was evaluated for their insight into their perceived
illness severity and perceived sensitivity, or the degree to
which they felt threatened by their illness.32 This was per-
formed by means of 3–5 group sessions in the preinter-
vention phase. Group sessions included 3–5 patients and
lasted for 45–60 min each. Session content included
assessments of the participants’ psychological and phys-
ical conditions as well as their attitude towards the nature,
definition, risk factors, symptoms, medical and nursing
care, and complications resulting from the MI.
In stage 2, patients were assessed for their expectations
over 3–5 1 h sessions.32 Groups of 3–4 patients shared
and learnt from each other under the moderation and
guidance of the principal researcher.
In stage 3, the degree of patient acceptance was assessed
using an educational participation method in group dis-
cussion. Patients reached practical solutions through
using the problem-solving findings of the previous stage.
Stage 4 consisted of formative and summative evalua-
tions.32 The aim of the formative evaluation was to
encourage patients to internalise their locus of control
by seeing his/her self-empowerment (increasing self-
responsibility about their health). Summative evaluations
were performed to evaluate the influence of the inter-
vention on HRQoL dimensions, perceived stress and
anxiety. The HRQoL dimensions, perceived stress and
anxiety were assessed at baseline and at 3 months post-
intervention. Empowerment was measured at baseline
and at 10 days postintervention by deploying FCEM
questionnaires.
Figure 1 Study overview and design. AMI, acute myocardial infarction; CK, creatine kinase; FCEM, Family-Centered
Empowerment Model; SF-36, 36-Item Short Form Health Survey.
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Phase 3 began 90 days following preintervention
(control group), and 90 days postintervention (FCEM
group). To assess the durability and stability of patient
empowerment, patient knowledge, attitude and practice
(KAP) was assessed over eight follow-up sessions at
3-month intervals. During the 24-month follow-up
period, patients attended a total of 21 support-group
webinars addressing topics including returning to work,
intimate relationships, nutrition, sleep hygiene, tobacco
use, exercise, and leisure activities and testing or labora-
tory issues. Follow-up interviews were conducted during
home visits, when available, or with the assistance of tele-
phone, Skype, Viber or WhatsApp according to patient
preference.
Role of the designee
Following informed consent, the designated family
member or friend (hereafter called designee) continued
through the study with the patient as a ‘unit’. The
designee attended the patient’s educational sessions
during stages 3 and 4, with stage 2 being according to
the family member preference. Recall that stage 2 deals
with patient expectations, stage 3 with patient accept-
ance and problem-solving, and stage 4 with evaluations
and internalising his/her locus of control. The designee
and the patient attended the same sessions, and studied
the same learning materials. Up to four family members
were allowed to join in the educational sessions if
requested. In stage 3, the designee was charged with
learning and reinforcing educational material with the
patient. In stage 4, when instructed by study investiga-
tors, the designee would administer the KAP assessments
to the patient. In addition to scores, the designee would
provide additional information on the patient’s home
situation and current condition. Patients were assigned a
code, and de-identified data were transmitted from the
designee to investigators either by encrypted email, tele-
phone, mail or in person.
Rehabilitation plan
All patients had similar inpatient rehabilitation pro-
grammes. For patients in the FCEM group, outpatients
included daily exercise for 0–2 h/day. Exercise
occurred between 8:00 and 10:00, and types included
walking, jogging, bicycle, swimming, or other exercise
according to patient preference or resource availability.
Daily exercise was supervised by designated family
members. Investigators randomly attended sessions in
an unannounced fashion. Although not routinely
involved, physical therapy consultation was available on
investigator request. Exercise data were independently
collected from the patient and their designated
family member on a weekly basis (κ statistic=0.9). To
measure the patients’ walking distance, investigators
provided them with a Fitbit (Fitbit, San Francisco,
USA). Routine care included education on smoking
cessation and education on food selection. Patients
were provided printed materials, with dietician assess-
ments available on request.
Patients in the control group received the same educa-
tion and printed materials during their inpatient course.
Patients exercised daily, at any time, for ≤2 h according
to patient tolerance. Sessions were supervised by family
members. Investigators did not attend sessions. Exercise
data were independently collected from the patient and
their designated family member on a weekly basis (κ stat-
istic=0.4). Again, walking distance was measured using
the Fitbit. Routine care included education on smoking
cessation and education on food selection. Patients were
provided printed materials, with dietician assessments
available on request.
Data collection
Data collection tools consisted of six questionnaires
including (1) demographic variables, (2) the FCEM, (3)
the 36-Item Short Form Health Survey (SF-36), (4) the
perceived stress, and (5) State and (6) Trait Anxiety
questionnaires. In addition to questionnaires, results of
serum creatinine, ejection fraction as measured on echo-
cardiography, and cardiac catheterisation and stenting
were also recorded.
The FCEM questionnaire
The FCEM questionnaire consisted of four dimensions:
perceived threat, self-efficacy, self-esteem, and summative
and formative evaluations.7 32 Degree of patient
empowerment was assessed via KAP questions. Each
question was scored on a scale of 1–7 representing least
to most empowerment, respectively. The maximum ques-
tionnaire score was 826, and the lowest acceptable score
was 620 (sensitivity 95%, specificity 96%).To determine
the lowest acceptable postintervention score, analysis of
the receiver operating characteristic (ROC) curve was
performed and discussed in two qualitative expert panel
rounds. Each expert panel consisted of 10 professional
members (2 cardiologists, 1 intensivist, 1 nutritionist, 3
registered nurses, 1 psychologist, 1 psychiatrist and 1
physiatrist) and 22 patient/family member units. The κ
agreement correlation coefficient among the two quali-
tative expert panel rounds’ results was 0.92.
Validity of the FCEM questionnaires was assessed by
face and content validities through both qualitative and
quantitative means. Impact score of the questionnaire
was calculated at 3.01; content validity ratio (CVR) with
10 panellists and Content Validity Index (CVI) were cal-
culated at 0.78 and 0.85, respectively. The reliability of
the FCEM questionnaire was assessed by test–retest and
Cronbach’s α that was calculated at 0.89 and 0.92,
respectively.32
SF-36 questionnaire
The questionnaire consists of eight domains including
physical functioning, physical role limitation, social func-
tioning, bodily pain, mental health, mental role limita-
tion, vitality and general health. Scoring of each domain
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was calculated independently and scores ranged from 0
(the worst) to 100 (the best).32 33 The SF-36 question-
naire is a validated tool33 34 whose reliability in this study
was assessed by test–retest and Cronbach’s α at 0.90 and
0.93, respectively.
The 14-item Perceived Stress Questionnaire (PSQ-14)
Overall stress was measured using the validated
PSQ-14.35 36 PSQ-14 scores are obtained by reversing the
scores on the seven positive items, including 0=4, 1=3,
2=2, 3=1 and 4=0, then, summing across all 14 items.
Scores range from 14 to70.37 The reliability of the
PSQ-14 was assessed in this study by test-retest and
Cronbach’s α at 0.93 and 0.92, respectively.
The State and Trait Anxiety questionnaire
Patient anxiety was assessed through the State–Trait
Anxiety questionnaire. This validated tool has 20 items
for assessing trait anxiety and state anxiety, respect-
ively.38 39 All items are rated on a four-point scale
ranging from very low (1 point) to very high (4 points).
Higher scores indicate greater anxiety.38 39 The reliabil-
ity of the State–Trait Anxiety questionnaire was assessed
in this study by test–retest and Cronbach’s α at 0.89 and
0.90, respectively.
Data analysis
All analyses were performed using SPSS 22.0 (SPSS Inc,
Chicago, IL). Frequency (per cent) and mean (SD)
were presented for qualitative variables (gender, marital
status, educational level, job and location of residence)
and quantitative variables (age, body mass index and
family size). Demographic variables were analysed using
the χ2 test and independent Student’s t test. The nor-
mality in variable distribution was analysed using the
Kolmogorov-Smirnov test (p>0. 05). For the outcome
measures of quality of life, perceived stress and
state-and-trait anxiety, repeated measures analysis of vari-
ance (RANOVA) was performed followed by Sidak post
hoc test.
The assumption of the sphericity of the covariance
matrix was evaluated using Mauchly’s test and, depend-
ing on the results of this test, p values were presented on
the basis of the Greenhouse-Geisser correction. In add-
ition, Hotelling’s T2 tests were used to evaluate the dif-
ferences between the intervention and control groups at
all time points, followed by independent samples
Student’s t tests for investigating the differences between
the intervention and control groups separately. p Values
<0.05 were considered significant.
RESULTS
A total of 127 eligible patients were screened for the
study. Fifty-one did not meet the inclusion criteria and
six declined to participate. Seventy patient–family units
were included and evenly randomised into two groups.
Three patients died, including two in the control
group and one in the intervention group. Seven
patients were lost to follow-up, including five in the
control group and two in the intervention group.
Patient demographics were similar between groups
(table 1).
Clinical and physiological variables
ST segment elevation MI was identified in 33 (94%)
patients in the intervention group and 31 (89%) in the
control group (p=0.77). Non-ST segment elevation MI
was identified in 2 (6%) versus 4 (11%) patients
(p=0.70). The incidence of cardiac catheterisation was
similar between groups (55% vs 40%; p=0.87). Among
those undergoing cardiac catheterisation, rates of stent
placement did not differ significantly (45% vs 60%;
p=0.62). Although the baseline ejection fraction did not
differ significantly between groups (table 2), the mean
and median ejection fractions were significantly higher
in the intervention group at measurements 2 (p=0.01)
and 3 (p=0.001).
There were no events of repeat MI or emergent revas-
cularisation in either group during the study period.
Renal function was similar between the intervention
and control groups. Serum creatinine did not differ
between groups at baseline (1.48±0.34 vs 1.39±0.40;
p=0.36), measurement 2 (1.28±0.34 vs 1.20±0.40; p=0.41)
and measurement 3 (1.08±0.34 vs 1.02±0.40; p=0.55).
Pearson and Spearman correlation coefficients (r)
were used to compare exercise, weight loss and smoking
cessation (data not presented). The correlation coeffi-
cients for exercise (r=0.90), weight loss (r=0.88) and
smoking cessation (r=0.90) indicate that changes in
these variables were similar between groups.
Exercise tolerance was further addressed by measuring
the walking distance once a month. The mean walking
distance was similar between groups at baseline but stat-
istically improved in the FCEM group relative to controls
(figure 2).
Quality of life
In this study, eight dimensions of quality of life were
summarised in two comprehensive domains including
physical dimensions (physical functioning, physical role
limitation, bodily pain and general health) and mental
dimensions (social functioning, mental health, mental
role limitation and vitality). The results of the RANOVA
model for physical and mental dimensions showed sig-
nificant changes within and between groups over time
(p<0.0001) (table 3).
Although the baseline physical health scores were
similar between groups (p=0.24), by the first postinter-
vention assessments scores were significantly higher in
the experimental group (p<0.0001) and remained so
throughout the duration of the study (table 3). Similarly,
the preintervention mental health scores were similar
between groups (p=0.48) but displayed a trend towards
significant improvement in the experimental group by
the first postintervention assessment and remained
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significant throughout the duration of the study
(p<0.0001).
Effect of the FCEM on perceived stress
The results of the RANOVA model showed similar base-
line values between the control and experimental
groups (p=0.48). A significant time trend was observed
in the intervention group (p<0.0001) with interaction
between time and group (p<0.0001; table 4).
No significant time trend was noted in the control
group (p=0.143). Of note, the difference within groups
was achieved by the first follow-up assessment and











Mean±SD 61.40±12.83 62.00±14.18 60.80±11.51 t=0.389*
p=0.699
BMI
Mean±SD 24.87±3.80 24.70±3.5 25.3±4.12 t=−0.364*
p=0.717
Family number
Mean±SD 5.37±1.91 5.2±1.94 5.54±1.91 t=−0.754*
p=0.454
Gender, n (%)
Male 46 (65.7%) 22 (62.9%) 24 (68.6%) χ2=2.470†
Female 24 (34.3%) 13 (37.1%) 11 (31.4%) df=1
p=0.116
Marital Status, n (%)
Single 1 (1.4%) 1 (2.9%) 0 (0.00%) –
Married 69 (98.6%) 34 (97.1%) 35 (100.0%)
Living location, n (%)
City 36 (51.4%) 20 (57.1%) 16 (45.7%) χ2=0.345†
df=1
p=0.557
Countryside 34 (48.6%) 15 (42.9%) 19 (54.3%)
Job, n (%)
Clerk 12 (17.1%) 4 (11.4%) 8 (22.9%) χ2=29.085†
df=25
p=0.260
Labourer 8 (11.4%) 4 (11.4%) 4 (11.4%)
Housekeeper 23 (32.9%) 13 (37.1%) 10 (28.6%)
Unemployed 3 (4.3%) 1 (2.9%) 2 (5.7%)
Retired 11 (15.7%) 5 (14.3%) 6 (17.1%)
Non-governmental 13 (18.6%) 8 (22.9%) 5 (14.3%)
Education level, n (%)
Primary 19 (27.1%) 8 (22.9%) 11 (31.4%) χ2=8.809†
df=4
p=0.066
Secondary 30 (42.9%) 17 (48.6%) 13 (37.1%)
High/undergraduate 21 (30.0%) 10 (28.6%) 11 (31.4%)
*Based on the independent Student’s t test.
†Based on the χ2 test.
BMI, body mass index.





























Preintervention 44 (33–50) 37 (34–43) 0.12 41.77±8.63 38.86±6.73 0.12 0.001 0.869 0.001
Measurement 2 46 (34–52) 38 (33–43) 0.01 43.43±8.65 38.66±6.79 0.01
Measurement 3 47 (36–53) 38 (33–44) 0.001 45.20±8.62 38.89±6.58 0.001
*p Value based on independent samples Student’s t test.
†p Value based on RANOVA.
FCEM, Family-Centered Empowerment Model; RANOVA, repeated measured analysis of variance.
6 Vahedian-Azimi A, Miller AC, Hajiesmaieli M, et al. Open Heart 2016;3:e000349. doi:10.1136/openhrt-2015-000349
Open Heart
 on M












maintained throughout the duration of the study
(p<0.0001).
Effect of the FCEM on state and trait anxiety
The results of the RANOVA model for state anxiety
showed similar preintervention values between groups
(p=0.84) but significant improvement in state anxiety
between groups by the first postintervention assessment
(p<0.0001; table 5).
This trend persisted for the duration of the study. The
time trend was significant in the intervention group and
displayed interaction between time and group
(p<0.0001), but no significant time trend was observed
within the control (p=0.063) in the control group.
When assessing trait anxiety, the RANOVA model
showed no significant time trend for either the interven-
tion (p=0.089) or control (p=0.095) group, and inter-
action between time and group (p=0.075). Overall, no
significant difference in trait anxiety was observed
between groups (table 5).
DISCUSSION
CR is an outpatient model of chronic disease manage-
ment for secondary CVD prevention and is a class I indi-
cation for patients with coronary heart disease.17 It can
be defined as ‘The coordinated sum of activities
required to influence favorably the underlying cause of
cardiovascular disease, as well as to provide the best pos-
sible physical, mental and social conditions, so that the
patients may, by their own efforts, preserve or resume
optimal functioning in their community and through
improved health behavior, slow or reverse progression of
disease’.40 In a meta-analysis, CR significantly reduced
all-cause mortality by 13–26%, cardiac mortality by 20–
36%, myocardial re-infarction by 25–47%, and risk
factors.1 Additionally, it has been reported to have bene-
ficial effects on quality of life, perceived stress and
anxiety.18 41 Patients who participate in CR tend to have
a higher HRQoL and improved markers of mental
health such as work resumption, and less stress and
anxiety. It has been shown that about 80% of partici-
pants attending CR return to physical, mental and psy-
chosocial functioning (including work) 1 year
post-hospitalisation for MI.42 Although cost-effective in
high-income countries, this has not been studied in
LMICs.1 20 Despite recommendations, CR remains
underutilised with low participation and adherence rates
in both high income and LMICs.1 In the USA, fewer
than 30% of eligible patients participate in these pro-
grammes,43 and fewer than 20% of eligible patients are
referred to these programmes.44 Rates in Iran have not
been well described. Many reasons for this underutilisa-
tion have been cited including age, female gender, geo-
graphic access, low socioeconomic status, organisational
and patient factors, and patient education and under-
standing of the nature of CR and the associated bene-
fits.19–21 45 Additionally, lower enrolment and higher
dropout rates have been seen with patients with coexist-
ing poor functional capacity and exercise habits,
tobacco use and depression with an onset pre-CR.46
As a means to improve patient accessibility and com-
pliance to CR programmes, both hybrid and home-
based programmes were developed. Hybrid programmes
incorporate both an ambulatory and home-based com-
ponent. Participation in hybrid and home-based CR is
associated with cost-effective and equivalent benefits to
supervised programmes and offers support to maintain
motivation, address anxiety and seek information.22–24
With advances in technology, hybrid home-based pro-
grammes have been developed that incorporate email,
secure websites and video conferencing between patients
and providers. Recently, the utility of smartphone appli-
cations to improve CR utilisation has also been investi-
gated.21 47 It has been shown that hybrid CR may be a
viable and effective tool in rural Iran.48
The FCEM is a model that we adapted to hybrid CR
for the purpose of improving patient quality of life. It
was initially designed to improve the care and outcomes
of patients with chronic diseases and has previously
been evaluated and validated in a number of chronic
disease states.7 25 26 28 30 31 49 50 Previously, it has been
shown that the FCEM model may be feasible to use in
the cardiac setting.7 32 Moreover, it has been reported to
be effective among patients undergoing coronary artery
bypass surgery.26 We investigated whether FCEM in the
post-MI care and CR process is an effective means to
decrease anxiety and perceived stress, and improve
HRQoL in patients hospitalised for MI. This was the first
study of its kind in this population. Control patients
received standard CR while those in the intervention
group received CR via the FCEM. For patients in the
FCEM group, the designated key support relationships
were identified and incorporated into their treatment
Figure 2 Distance walked daily. FCEM, Family-Centered
Empowerment Model.
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plan. Through stage 1, patients are encouraged to learn
about themselves and their health so that they may be
able to identify the ways in which they feel threatened by
their illness. They then learn to assess their expectations
of these situations (stage 2), and brainstorm in groups
via the educational participation method to develop
practical solutions (stage 3). Lastly, patients are taught to
do a self-assessment and internalise their locus of
control. In this way, patients are being taught techniques
to cope with their chronic illness over the long haul.
In this study, we found improvements in physical
health, mental health and quality of life in those
patients receiving home CR using the FCEM as com-
pared with those receiving standard home CR. The
reasons for improvement are most likely multifactorial
and may include patient encouragement, greater patient















Physical health Baseline 52.76±9.59 50.11±9.58 0.242 <0.0001 <0.0001 <0.0001
Measurement 2 82.05±6.40 25.6±9.44 <0.0001
Measurement 3 82.04±9.30 26.06±8.20 <0.0001
Follow-up 1 81.01±7.20 24.24±10.24 <0.0001
Follow-up 2 86.13±4.51 27.81±7.61 <0.0001
Follow-up 3 88.37±3.42 20.10±4.65 <0.0001
Follow-up 4 88.54±3.35 22.91±7.15 <0.0001
Follow-up 5 88.31±3.49 22.25±7.69 <0.0001
Follow-up 6 87.66±3.47 27.53±7.12 <0.0001
Follow-up 7 81.01±7.20 34.24±10.24 <0.0001
Follow-up 8 85.21±4.65 23.01±4.87 <0.0001
Mental health Baseline 51.92±9.51 53.64±10.87 0.483 <0.0001 <0.0001 <0.0001
Measurement 2 80.11±7.40 23.35±8.34 <0.0001
Measurement 3 81.21±7.30 25.25±6.34 <0.0001
Follow-up 1 79.41±6.20 24.15±7.14 <0.0001
Follow-up 2 85.72±3.23 24.43±7.82 <0.0001
Follow-up 3 85.17±3.34 18.33±4.45 <0.0001
Follow-up 4 84.69±3.45 22.89±7.56 <0.0001
Follow-up 5 84.78±3.86 24.52±8.15 <0.0001
Follow-up 6 84.04±3.78 21.74±5.93 <0.0001
Follow-up 7 79.41±6.20 24.15±7.14 <0.0001
Follow-up 8 83.86±3.81 20.44±5.48 <0.0001
*p Value based on independent samples Student’s t test.
†p Value based on repeated measures ANOVA. Dependent on the results of Mauchly’s test, p values presented are based on the
Greenhouse-Geisser test.
ANOVA, analysis of variance; FCEM, Family-Centered Empowerment Model; SF-36, 36-Item Short Form Health Survey.






p Value within the
FCEM group†




Baseline 34.57±3.83 33.49±2.71 0.483 <0.0001 0.143 <0.0001
Measurement 2 67.69±0.91 32.69±3.11 <0.0001
Measurement 3 70.26±0.54 31.61±3.10 <0.0001
Follow-up 1 68.17±1.51 34.51±3.25 <0.0001
Follow-up 2 68.46±0.95 33.60±2.06 <0.0001
Follow-up 3 68.34±1.14 34.00±2.24 <0.0001
Follow-up 4 68.54±1.07 33.77±2.36 <0.0001
Follow-up 5 68.34±1.06 34.37±2.21 <0.0001
Follow-up 6 68.40±1.19 33.63±2.30 <0.0001
Follow-up 7 68.60±1.38 34.35±1.97 <0.0001
Follow-up 8 64.71±1.98 33.66±2.11 <0.0001
*p Value based on independent samples Student’s t test.
†p Value based on repeated measures ANOVA. Dependent on the results of Mauchly’s test, p values presented are based on the
Greenhouse-Geisser test.
ANOVA, analysis of variance; FCEM, Family-Centered Empowerment Model.
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understanding, positive reinforcement and the sense of
accountability. This is reflected in the results of physical
and mental health scores. Baseline scores were similar
between groups; however, following deployment of the
FCEM with its educational and support groups and use
of remote follow-up (telephone, Skype, Viber or
WhatsApp), there was a sharp discrepancy between
groups favouring the FCEM-enhanced CR over standard
home-based CR. Similar results were observed for per-
ceived stress and state anxiety. The non-significance of
the trait anxiety findings is important. State anxiety
refers to a temporary condition in response to some per-
ceived threat. Trait anxiety refers to the differences
between people in terms of their tendency to experi-
ence state anxiety in response to the anticipation of a
threat (ie, anxiety proneness). Thus, trait anxiety
describes a personality characteristic rather than a tem-
porary feeling. Although traits are enduring features
which are part of one’s personality, the expression of a
trait can be changed over time, for example, with the
use of long-term therapy. The importance of measuring
trait anxiety in this study was to demonstrate that anxiety
proneness, or the ability to generate state anxiety, was
similar between groups. We observed stable levels of trait
anxiety in both groups throughout the study. We believe
that the attenuation in the rise in situational, or state,
anxiety in the interventional group is a reflection of the
patient’s sense of empowerment in managing their
health situation. Moreover, our interventions did not
incorporate mandatory therapy or interventions that
would change the trait anxiety of patients; thus, these
levels remained stable.
Further study is needed to discern whether the FCEM
is really improving patient health versus attenuating the
decline that may occur following discharge for AMI. It
may be that the FCEM method augments and maintains
the education and empowerment that patients receive
during their inpatient course. Additionally, the long-
term sustainability of this method in this setting remains
to be investigated.
CONCLUSION
The FCEM is an effective CR method for improving a
patient’s mental health and personal assessments of
physical health following AMI.
LIMITATIONS
Physical health was measured by the validated SF-36
questionnaire. Data regarding specific modifiable risk
factors (blood pressure, cholesterol, glycated haemoglo-
bin) were not recorded.
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State anxiety Baseline 55.37±7.21 55.06±6.23 0.846 <0.0001 0.143 <0.0001
Measurement 2 53.23±7.98 73.14±6.05 <0.0001
Measurement 3 54.30±4.32 76.09±4.54 <0.0001
Follow-up 1 55.83±6.69 71.34±5.40 <0.0001
Follow-up 2 55.11±6.16 74.34±3.51 <0.0001
Follow-up 3 54.69±6.43 72.31±5.10 <0.0001
Follow-up 4 55.29±5.56 71.97±4.94 <0.0001
Follow-up 5 55.00±6.34 71.71±4.10 <0.0001
Follow-up 6 53.09±4.97 72.00±5.04 <0.0001
Follow-up 7 51.94±3.12 71.94±4.43 <0.0001
Follow-up 8 54.23±5.30 72.26±4.24 <0.0001
Trait anxiety Baseline 54.49±4.36 53.43±3.85 0.285 0.089 0.095 0.075
Measurement 2 52.23±4.17 53.40±4.56 0.921
Measurement 3 51.23±4.80 53.29±5.54 0.729
Follow-up 1 53.86±3.87 52.20±4.63 0.109
Follow-up 2 53.43±3.85 54.49±4.36 0.406
Follow-up 3 52.20±4.63 53.86±3.87 0.801
Follow-up 4 54.06±3.69 54.14±4.39 0.930
Follow-up 5 52.20±4.63 53.43±3.85 0.231
Follow-up 6 54.49±4.36 52.20±4.63 0.099
Follow-up 7 53.20±4.63 52.20±4.63 0.942
Follow-up 8 55.06±3.69 54.06±3.70 0.843
FCEM, Family-Centered Empowerment Model.
*P-value based on independent samples T-test.
†P-value based on repeated measures ANOVA. Dependent on the results of Mauchly’s test, P-values presented are based on the
Greenhouse-Geiser test.
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